» Articles » PMID: 27657335

Dengue Protease Substrate Recognition: Binding of the Prime Side

Overview
Journal ACS Infect Dis
Date 2016 Sep 23
PMID 27657335
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Dengue virus (DENV), transmitted predominantly in tropical and subtropical regions by the mosquito Aedes aegypti, infects millions of people and leads to dengue fever and thousands of deaths each year. There are no direct-acting antivirals to combat DENV, and molecular and structural knowledge is required to develop such compounds. The dengue NS2B/NS3 protease is a promising target for direct-acting antivirals, as viral polyprotein cleavage during replication is required for the maturation of the viral particle. The NS2B/NS3 protease processes 8 of the 13 viral polyprotein cleavage sites to allow viral maturation. Although these sites share little sequence homology beyond the P1 and P2 positions, most are well conserved among the serotypes. How the other substrate residues, especially at the P' side, affect substrate recognition remains unclear. We exploited the tight-binding general serine protease inhibitor aprotinin to investigate protease-substrate interactions at the molecular level. We engineered aprotinin's binding loop with sequences mimicking the P' side of DENV substrates. P' residues significantly modulate substrate affinity to protease, with inhibition constants varying from nanomolar to sub-millimolar. Structural and dynamic analysis revealed the molecular basis of this modulation and allowed identifying optimal residues for each of the P' positions. In addition, isothermal titration calorimetry showed binding to be solely entropy driven for all constructs. Potential flaviviral P' side inhibitors could benefit from mimicking the optimal residues at P' positions and incorporate hydrophobicity and rigidity to maintain entropic advantage for potency.

Citing Articles

Evaluating the specificity of flavivirus proteases in Aedes aegypti cells for dengue virus 2-derived cleavage sites.

Dingle A, Adelman Z PLoS One. 2024; 19(12):e0309095.

PMID: 39625906 PMC: 11614287. DOI: 10.1371/journal.pone.0309095.


The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.

Starvaggi J, Previti S, Zappala M, Ettari R Int J Mol Sci. 2024; 25(8).

PMID: 38673962 PMC: 11050111. DOI: 10.3390/ijms25084376.


Natural Polymorphisms D60E and I62V Stabilize a Closed Conformation in HIV-1 Protease in the Absence of an Inhibitor or Substrate.

Tran T, Fanucci G Viruses. 2024; 16(2).

PMID: 38400012 PMC: 10892587. DOI: 10.3390/v16020236.


Finding Lead Compounds for Dengue Antivirals from a Collection of Old Drugs through Target Prediction and Subsequent Validation.

Abdullah Z, Chee H, Yusof R, Mohd Fauzi F ACS Omega. 2023; 8(36):32483-32497.

PMID: 37720780 PMC: 10500654. DOI: 10.1021/acsomega.3c02607.


Differential localization of dengue virus protease affects cell homeostasis and triggers to thrombocytopenia.

Gandhi L, Maisnam D, Rathore D, Chauhan P, Bonagiri A, Venkataramana M iScience. 2023; 26(7):107024.

PMID: 37534186 PMC: 10391676. DOI: 10.1016/j.isci.2023.107024.


References
1.
Ozen A, Lin K, Yilmaz N, Schiffer C . Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease. Proc Natl Acad Sci U S A. 2014; 111(45):15993-8. PMC: 4234576. DOI: 10.1073/pnas.1414063111. View

2.
Green S, Rothman A . Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006; 19(5):429-36. DOI: 10.1097/01.qco.0000244047.31135.fa. View

3.
Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W . Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. J Chem Theory Comput. 2015; 6(5):1509-19. DOI: 10.1021/ct900587b. View

4.
Malcolm B, Liu R, Lahser F, Agrawal S, Belanger B, Butkiewicz N . SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother. 2006; 50(3):1013-20. PMC: 1426438. DOI: 10.1128/AAC.50.3.1013-1020.2006. View

5.
Li J, Pheng Lim S, Beer D, Patel V, Wen D, Tumanut C . Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem. 2005; 280(31):28766-74. DOI: 10.1074/jbc.M500588200. View